Showing 21-30 of 57 results for "".
- Positive Topline Results from Pivotal Phase 3 Trial of Arcutis Biotherapeutics' Roflumilast Foam in Scalp and Body Psoriasishttps://practicaldermatology.com/news/positive-topline-results-from-pivotal-phase-3-trial-of-arctuis-biotherapeutics-roflumilast-foam-in-scalp-and-body-psoriasis/2461359/Topline results from the ARRECTOR Pivotal Phase 3 trial evaluating Arcutis Biotherapeutics, Inc.'s roflumilast foam 0.3% were positive for the treatment of adults and adolescents with scalp and body psoriasis. The study met its co-primary endpoints of S-IGA Success and B-IGA Success, and all second…
- ASLMS Announces New Officershttps://practicaldermatology.com/news/aslms-announces-new-officers-1/2461215/Paul M. Friedman, MD is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Friedman, board-certified by the American Board of Dermatology, is the director of Dermatology & Laser Surgery Center of Houston, Texas. He is a clinical assistant professor at the Univers…
- New Two-Year Data on Deucravacitinib Reinforce Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasishttps://practicaldermatology.com/news/new-two-year-on-bms-deucravacitinib-data-reinforce-efficacy-and-safety-profile-in-treatment-of-moderate-to-severe-plaque-psoriasis/2461191/Bristol Myers Squibb shared new two-year results from the POETYK PSO long-term extension (LTE) trial demonstrating durable efficacy and a consistent safety profile with deucravacitinib treatment in adult patients with moderate to severe plaque psoriasis. Clinical efficacy was maintained through up …
- NPF Task Force Issues New Guidance on COVID-19 Vaccine Boosters for PsO Patientshttps://practicaldermatology.com/news/npf-task-force-issues-new-guidance-on-covid-19-vaccine-boosters-for-pso-patients/2460911/The Centers for Disease Control and Prevention (CDC) recently released new information on COVID-19 vaccines for moderately to severely immunocompromised people. Since these individuals may be especially vulnerable to COVID-19, due to their increased risk of serious, prolonged illness, the CDC recom…
- Study: Skin Reactions After COVID-19 Vaccines Are Rarehttps://practicaldermatology.com/news/study-skin-reactions-after-covid-19-vaccines-are-rare/2460848/Skin problems such as itchiness, rashes, hives and swelling can occur in some individuals after receiving a COVID-19 vaccine, but new research suggests that these reactions are rare, and that even when they do occur with an initial COVID-19 vaccination, they seldom recur after receiving a second va…
- NPF COVID-19 Task Force: Masks, Social Distancing Still Important for Many Vaccinated Psoriasis Patientshttps://practicaldermatology.com/news/npf-covid-19-task-force-masks-social-distancing-still-important-for-many-vaccinated-psoriasis-patients/2460818/In mid-May 2021, the Centers for Disease Control and Prevention (CDC) released new public health recommendations for fully vaccinated individuals. These guidelines stated that fully vaccinated people no longer need to wear a mask or physically distance in any setting, except where required by law, …
- ASLMS Announces New Officershttps://practicaldermatology.com/news/aslms-announces-new-officers/2460816/Henry H.L. Chan, MD, PhD, FRCP, is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Chan is currently the Honorary Clinical Professor and Honorary Consultant Dermatologist of the Division of Dermatology, Department of Medicine, The University of Hong Kong, Quee…
- Metabolic Syndrome Linked to Higher Cardiovascular Risk in Psoriasis Patientshttps://practicaldermatology.com/news/metabolic-syndrome-linked-to-higher-cardiovascular-risk-in-psoriasis-patients/2460645/Metabolic syndrome in people with psoriasis may contribute to an increased risk of heart disease, according to a study in the Journal of the American Association of Dermatology. “Metabolic syndrome (MetSyn), so common among our psoriasis patients, drives up coronary artery disease in this populati…
- Study: “Baby Botox” Boosts Skin Texture, Shrinks Poreshttps://practicaldermatology.com/news/study-baby-botox-boosts-skin-texture-shrinks-pores/2460603/Using many tiny doses of botulinum toxin injected in a grid pattern just under the surface of the facial skin may improve skin texture and roughness, according to a study in the November issue of Plastic and Reconstructive Surgery. The “Microbotulinum” technique is a safe and effective method of f…
- ICYMI: ASA Honors Drs. Doris Day and Mark Lebwohl at Virtual Galahttps://practicaldermatology.com/news/icymi-asa-honors-drs-doris-day-and-mark-lebwohl-at-virtual-gala/2460521/Dermatologists Drs. Doris Day and Mark Lebwohl took home top awards at the American Skin Association’s (ASA) annual gala, which was held virtually this year. Dr. Day, a clinical associate professor of dermatology at NYU Langone Medical Center, received ASA's Excellence in Dermatology Mentorship Aw…